Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CSF polyamines. Potential as brain tumor markers.

L J Marton

    Archives of Neurology
    |February 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Cerebrospinal fluid (CSF) polyamine levels show promise for detecting brain tumors, particularly for diagnosing and managing medulloblastoma patients. This biomarker aids in understanding and treating this specific pediatric brain cancer.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Polyamine-DNA Interactions: Possible Site of New Cancer Chemotherapeutic Intervention.

    Pharmaceutical research·2013
    Same author

    The polyamine analog PG11047 potentiates the antitumor activity of cisplatin and bevacizumab in preclinical models of lung and prostate cancer.

    Cancer chemotherapy and pharmacology·2009
    Same author

    Antizyme and antizyme inhibitor activities influence cellular responses to polyamine analogs.

    Amino acids·2007
    Same author

    Molecular basis of inward rectification: structural features of the blocker defined by extended polyamine analogs.

    Molecular pharmacology·2005
    Same author

    SL-11158, a synthetic oligoamine, inhibits polyamine metabolism of Encephalitozoon cuniculi.

    The Journal of eukaryotic microbiology·2002
    Same author

    Conformationally restricted analogues of 1N,14N-bisethylhomospermine (BE-4-4-4): synthesis and growth inhibitory effects on human prostate cancer cells.

    Journal of medicinal chemistry·2001
    Same journal

    Incorrect Table Entries and Word.

    Archives of neurology·2016
    Same journal

    IDEAL for CCSVI Research-Reply.

    Archives of neurology·2013
    Same journal

    Atlas of Inherited Metabolic Diseases, 3rd ed.

    Archives of neurology·2013
    Same journal

    Error in byline: in heterogeneity of coenzyme q10 deficiency: patient study and literature review.

    Archives of neurology·2013
    Same journal

    This month in archives of neurology.

    Archives of neurology·2013
    Same journal

    About this journal.

    Archives of neurology·2013
    See all related articles

    Area of Science:

    • Neuro-oncology
    • Biomarker Discovery
    • Clinical Diagnostics

    Background:

    • Brain tumors represent a significant health challenge, necessitating improved diagnostic tools.
    • Cerebrospinal fluid (CSF) analysis is a valuable method for neurological disease assessment.
    • Polyamines are implicated in cellular growth and proliferation, suggesting their potential as tumor markers.

    Purpose of the Study:

    • To evaluate the utility of CSF polyamine levels in detecting brain tumors.
    • To specifically assess the diagnostic and prognostic value of CSF polyamine levels in medulloblastoma.

    Main Methods:

    • Review of existing literature on CSF polyamine levels and brain tumor detection.
    • Analysis of studies focusing on polyamine quantification in CSF samples.

    Related Experiment Videos

  • Correlation of polyamine levels with tumor presence and type, especially medulloblastoma.

    • Main Results:

    • CSF polyamine levels demonstrate potential as a non-invasive biomarker for brain tumor detection.
    • Elevated polyamine concentrations in CSF are associated with the presence of brain tumors.
    • Specific polyamine profiles may aid in the diagnosis and monitoring of medulloblastoma.

    Conclusions:

    • CSF polyamine levels offer a promising avenue for the early detection of brain tumors.
    • Further research is warranted to establish CSF polyamine levels as a standard diagnostic tool for medulloblastoma.
    • This biomarker could enhance patient care and treatment strategies for brain tumor patients.